Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Infections 2Soft Tissue Infections 1Neutropenia 1Lymphoma, Follicular 1Fournier Gangrene 1Fasciitis, Necrotizing 1

Interventions

Exercise 418Blood Specimen Collection 317Standard of Care 295Surveys and Questionnaires 241Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 222Methods 219Radiotherapy 216Early Intervention, Educational 199Practice Guidelines as Topic 140Interviews as Topic 139Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 100Palliative Care 97Resistance Training 93Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Specimen Handling 70Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × Daptomycin × Clear all
NCT00261807 2022-01-27

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

University of Maryland, Baltimore

Phase NA Completed
25 enrolled 7 charts
Lymphoid

Infections, Lymphoma, Follicular, Soft Tissue Infections, Fournier Gangrene, Fasciitis, Necrotizing

NCT00296049 2018-08-10

Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy

Wake Forest University Health Sciences

Phase NA Withdrawn

Infections, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡